跳至主要内容
临床试验/NCT03780998
NCT03780998Unknown不适用

Effects of Sodium Pentaborat Based Gel on Perianal Benign Diseases. Prospective Clinical Trial

SB Istanbul Education and Research Hospital0 个研究点目标入组 250 人开始时间: 2019年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
250
主要终点
Pain symtom differences

研究概览

简要总结

New produced and patented sodium pantaborat based gel will be use for treatment of benign perianal diseases (hemooroidal disease, anal fissura anda perianal fistula)

详细描述

Prospective randomised clinical trial planned. Older than 18 years old perianal benign diseases (grade 1 and 2 hemorroidal disease, anal fissura, uncomplicated simple perianal fistula) cases without malign tumour, cronic colorectal disases, and routine used of vasoactive medication cases were entered the study. Younger than 18 years old, diagnosed any malign tumor and/or cronic colorectal disaeses, routine used of vasoact,ve mediaction cases were exclused of the study.

Group-1 (n: 50): Healthy cases (control group) Group-2 (n:50): Grade 1 hemorroidal disease cases Group-3 (n:50): Grade 2 hemorroidal disease cases Group-4 (n:50): Anal fissure cases Group-5 (n:50): Uncomplicated, simple perianal fistula cases

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Grade 1 and 2 hemorroidal disease
  • Cronic anal fissura
  • Uncomplicated simple perianal fistula

排除标准

  • Any malign tumour
  • Cronic colorectal disases
  • Routine used of vasoactive medication

研究组 & 干预措施

Group-1 (n: 50): Healthy cases

Control group

干预措施: Life7 (Drug)

Group-2 (n:50): Grade 1 hemorroid

With perianal examination diagnosed of grade 1 hemorroidal disease

干预措施: Life7 (Drug)

Group-3 (n:50): Grade 2 hemorroid

With perianal examination diagnosed of grade 2 hemorroidal disease

干预措施: Life7 (Drug)

Group-4 (n:50): Anal fissure cases

With perianal examination diagnosed of anal fissure cases

干预措施: Life7 (Drug)

Group-5 (n:50): Simple perianal fistula

With perianal examination diagnosed of uncomplicated, simple perianal fistula cases

干预措施: Life7 (Drug)

结局指标

主要结局

Pain symtom differences

时间窗: six months

Pain Scale from level 1 to level 10.

Lowering of the grade of the hemorroidal disease (hemoroidal disease is four grades; grade 1, grade 2, grade 3, and grade 4)

时间窗: six months

Surgeon general physical examination

Closing of anal fissur line

时间窗: six months

Surgeon general physical examination. Fissur line is exist or not exist

Lowering of leakage amount of perianal fistule

时间窗: six months

Three grade: lower, same, more

次要结局

未报告次要终点

研究者

发起方
SB Istanbul Education and Research Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Erhan Aysan

MD Prof

Yeditepe University

相似试验